An official website of the United States government
NIH Guide: Weekly Index for September 13, 2024
Weekly NIH Guide Notices
September 13, 2024
General Notices
-
Notice of Pre-Application Webinar for Notices of Funding Opportunity RFA-CA-25-011 and RFA-CA-25-012: The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer
(NOT-CA-24-099)National Cancer Institute
-
Notice of Pre-Application Webinar for PAR-24-274 - NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
(NOT-CA-24-105)National Cancer Institute
-
Notice of Informational Webinar for the NIGMS Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T34 and UE5/T32)
(NOT-GM-24-058)National Institute of General Medical Sciences
-
Notice of Pre-Application Webinar for Ethical, Legal, and Social Implications (ELSI) Congress (U13, Clinical Trials Not Allowed)
(NOT-HG-24-050)National Human Genome Research Institute
-
NIH Grants Policy Updates: FY2025 Edition - Registration Open for October 17, 2024 Webinar
(NOT-OD-24-170)Office of the Director, NIH
-
Redesigned NIH Grants & Funding Website to Launch on September 24, 2024
(NOT-OD-24-171)National Institutes of Health
Notice of Changes to Funding Opportunities
-
Notice of Correction to Eligibility Information in "Cancer Prevention Clinical Trials Network (CP-CTNet)": RFA-CA-24-024 and RFA-CA-24-025
(NOT-CA-24-103)National Cancer Institute
-
Notice of Correction to RFA-CA-24-025, Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Statistical Center (DMASC) (UG1 Clinical Trial Required)
(NOT-CA-24-107)National Cancer Institute
-
Notice of Change to Reduce the Required Effort Level for Program Directors/Principal Investigators in PAR-22-180 Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)
(NOT-GM-24-054)National Institute of General Medical Sciences
-
Notice to Clarify Effort Requirements for Clinician Scientists with Surgical Specialties in the "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)" NOFOs
(NOT-GM-24-057)National Institute of General Medical Sciences
-
Notice to Extend Expiration Dates for PA-22-175 Competitive Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Enhance Workforce Diversity in Health Services Research
(NOT-HS-24-024)Agency for Healthcare Research and Quality
Notices of Intent to Publish
-
Notice of Intent to Publish a Notice of Funding Opportunity for Social Determinants of Health (SDoH) and Quality of Care Contributors to Cancer Disparities in People with HIV (U01; Clinical Trial Optional)
(NOT-CA-24-106)National Cancer Institute
-
Notice of Intent to Publish a Funding Opportunity Announcement for Precision Medicine for Type 1 Diabetic Nephropathy (U01 Clinical Trial Not Allowed)
(NOT-DK-24-036)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Intent to Publish a Funding Opportunity Announcement for NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
(NOT-HL-24-030)National Heart, Lung, and Blood InstituteNational Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
-
Notice of Intent to Publish a Funding Opportunity Announcement for NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
(NOT-HL-24-031)National Heart, Lung, and Blood Institute
Notices of Special Interest
-
Notice of Special Interest (NOSI): Career Development Opportunities for Research on Cancer in Global Settings at the Center for Global Health at the National Cancer Institute
(NOT-CA-24-098)National Cancer Institute
-
Notice of Special Interest (NOSI): Consequences of Prenatal Fentanyl Exposure
(NOT-DA-26-003)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Application of Artificial Intelligence in Treatment Development for Substance Use Disorders
(NOT-DA-26-005)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Availability of Administrative Supplements to Broaden the NIDDK Clinical Research Workforce
(NOT-DK-24-031)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Special Interest (NOSI): Developing and Delivering Feasible Screening Methods and Tools for Eating Disorders.
(NOT-MH-24-380)National Institute of Mental Health
-
Notice of Special Interest (NOSI): Administrative Supplement Program to Add Fluid-based Biomarkers and APOE Genotyping to NINDS ADRD Human Subjects Research Grants
(NOT-NS-24-135)National Institute of Neurological Disorders and StrokeNational Institute on Aging
Funding Opportunities
-
Coordinating Center to Support Consortium for Neuroscience Alzheimers Disease (AD) and AD-Related Dementias (ADRD) Research in Low- and Middle-Income Countries (LMICs) (U24 Clinical Trial Not Allowed)
(RFA-AG-25-014)National Institute on AgingApplication Receipt Date(s): Multiple dates, see announcement.
-
Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)
(RFA-DA-25-073)National Institute on Drug AbuseApplication Receipt Date(s): Not Applicable
-
Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R01 Clinical Trial Not Allowed)
(RFA-DE-25-001)National Institute of Dental and Craniofacial ResearchOffice of the Director, NIHApplication Receipt Date(s): November 19, 2024
-
Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R21 Clinical Trial Not Allowed)
(RFA-DE-25-002)National Institute of Dental and Craniofacial ResearchOffice of the Director, NIHApplication Receipt Date(s): November 19, 2024
-
Urology Centers Program Interactions Core (U24 Clinical Trial Not Allowed)
(RFA-DK-26-002)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): November 21, 2024
-
Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional)
(RFA-MD-24-012)National Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): November 18, 2024
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster